Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0SH0M
|
||||
Former ID |
DIB019217
|
||||
Drug Name |
compound 12
|
||||
Drug Type |
Small molecular drug
|
||||
Structure |
Download2D MOL |
||||
Formula |
C16H11NO5
|
||||
InChI |
InChI=1S/C16H11NO5/c1-9-2-4-10(5-3-9)22-11-6-7-12-13(8-11)15(19)17(14(12)18)16(20)21/h2-8H,1H3,(H,20,21)
|
||||
InChIKey |
QSPCKQSNISDWOH-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Lysophosphatidate-3 receptor | Target Info | Antagonist | [530422] | |
Pathway Interaction Database | LPA receptor mediated events | ||||
References | |||||
Ref 530422 | Structure-based drug design identifies novel LPA3 antagonists. Bioorg Med Chem. 2009 Nov 1;17(21):7457-64. | ||||
Ref 542018 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6989). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.